Seven Eight Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
Similar funds
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.